Baxter International has reported positive Phase III clinical trial results for its investigational haemophilia drug BAX 817. The recombinant factor VIIa …

Pfizer has announced that it is establishing a gene therapy platform as it looks to expand its rare diseases operations. …

Bayer HealthCare will pay up to $252 million to Dimension Therapeutics in a deal which sees the companies collaborate on …
Amsterdam Molecular Therapeutics has been granted an orphan drug designation for its gene therapy for haemophilia B.The FDA’s orphan designation …

Novo Nordisk is sponsoring an educational comic about haemophilia for young sufferers of the blood disorder in the UK. It …

Bayer Healthcare has launched a new disease awareness campaign that uses augmented reality techniques to engage with its target audience. …

Bayer Schering Pharma is counting down to World Haemophilia Day with a football-themed online disease awareness campaign. The centre-piece of …